Clare Market Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.05M Sell
4,212
-3
-0.1% -$3.06K 0.92% 20
2026
Q1
$3.88M Buy
+4,215
New +$4.27M 0.81% 23
2025
Q3
$2.94M Sell
3,849
-307
-7% -$228K 0.59% 29
2025
Q2
$3.24M Sell
4,156
-53
-1% -$41.2K 0.72% 28
2025
Q1
$3.48M Buy
4,209
+2,003
+91% +$1.67M 0.92% 20
2024
Q4
$1.7M Sell
2,206
-707
-24% -$585K 0.4% 36
2024
Q3
$2.58M Buy
2,913
+950
+48% +$854K 0.68% 20
2024
Q2
$1.78M Buy
1,963
+302
+18% +$242K 0.5% 29
2024
Q1
$1.29M Sell
1,661
-65
-4% -$46.3K 0.4% 39
2023
Q4
$1.01M Buy
1,726
+28
+2% +$16.3K 0.35% 40
2023
Q3
$912K Sell
1,698
-277
-14% -$143K 0.36% 39
2023
Q2
$926K Sell
1,975
-73
-4% -$30.6K 0.35% 46
2023
Q1
$703K Sell
2,048
-386
-16% -$130K 0.29% 47
2022
Q4
$891K Sell
2,434
-1,185
-33% -$420K 0.42% 34
2022
Q3
$1.17M Buy
3,619
+443
+14% +$140K 0.51% 27
2022
Q2
$1.03M Sell
3,176
-122
-4% -$36.6K 0.45% 30
2022
Q1
$945K Sell
3,298
-1,372
-29% -$353K 0.3% 48
2021
Q4
$1.29M Sell
4,670
-134
-3% -$34K 0.36% 36
2021
Q3
$1.11M Buy
4,804
+1,685
+54% +$416K 0.33% 41
2021
Q2
$716K Sell
3,119
-1,415
-31% -$284K 0.23% 62
2021
Q1
$847K Sell
4,534
-73
-2% -$14.3K 0.32% 49
2020
Q4
$778K Buy
+4,607
New +$688K 0.33% 46
2020
Q3
Sell
-1,396
Closed -$229K 119
2020
Q2
$229K Buy
+1,396
New +$214K 0.14% 75
2020
Q1
Sell
-5,086
Closed -$668K 87
2019
Q4
$668K Buy
+5,086
New +$590K 0.48% 41

Other funds holding LLY

Clare Market Investments's LLY Position: Q2 2026 in Review

Clare Market Investments reduced its Eli Lilly (LLY) stake by 0.07% in Q2 2026, selling an estimated $3.06K and leaving 4,212 shares worth $5.05M. The position accounts for 0.92% of the portfolio, ranked #20.

Clare Market Investments first reported a position in LLY in Q4 2019 and has held it in 24 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clare Market Investments held 4,212 shares of Eli Lilly worth $5.05M as of Q2 2026.
  • Clare Market Investments sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.92% of Clare Market Investments's portfolio in Q2 2026, its #20 holding.
  • Clare Market Investments first reported a position in Eli Lilly in Q4 2019 and has held it in 24 quarters since.
  • 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clare Market Investments's 13F filing for Q2 2026, filed 27 Jul 2026.